Use Of Gigstride Device In Patients With Lower Extremity Deficit (NCT06548087) | Clinical Trial Compass
CompletedNot Applicable
Use Of Gigstride Device In Patients With Lower Extremity Deficit
United States44 participantsStarted 2024-10-08
Plain-language summary
For patients with lower extremity deficits, the investigator(s) would like to assess implementing use of Gigstride ambulatory device to assess the following:
* Patient satisfaction with use of ambulatory device
* Effects of Gigstride device utilization on kinetics, biomechanics
* Effects of Gigstride device utilization on walking speed, stair speed, stability
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female, age \> 18
* Has undergone treatment for a lower extremity mobility deficit, with one of the following causatives Principal Diagnoses Osteoarthritis hip, knee, spine Pre or post hip replacement Pre or post knee replacement Multiple Sclerosis Mild to moderate central spinal stenosis Foot drop Degenerative changes, not otherwise specified Balance issues
* Recommended cane, brace, walker, Ankle Foot Orthoses, or electronic or robotic device for management
* Provide written consent for participation.
* Ability to wear shoes with laces
Exclusion Criteria:
* Inability to walk.
* Shoulder operation within 1 year preceding the study date.
* Injury due to a work accident (e.g. workers comp)
* Higher functions do not enable proper comprehension of protocol or reliable data recording.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested something called a 'GigStride device' for people with lower limb problems — is this the kind of walking aid that might be relevant for my specific mobility issue, and has my doctor seen the results?
2Since this was a feasibility study rather than a full efficacy trial, what does that mean in terms of how much we actually know about whether the GigStride device is safe and effective compared to other walking aids I might already be using?
3The trial is now completed and was measuring an 'ambulatory device aid score' — is there any way my doctor can access the published findings to see whether the device showed enough promise to be worth pursuing?
4Given that this trial focused on people with lower extremity deficits broadly, would my doctor consider my particular condition a good match for the kind of problems this device was designed to help with?
5Are there standard rehabilitation tools or walking aids already available that my doctor would recommend trying first, before considering a newer device like GigStride that is still in early feasibility testing?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Device Feasibility as assessed by ambulatory device aid score